Catalyst Wire Dossier Catalyst Wire Dossier

Paliperidone ER (Invega)

paliperidone · Janssen Pharmaceuticals (Johnson & Johnson)
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Paliperidone ER (Invega), covering 2011-06-08 to 2014-06-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder [Phase 3]

See pricing